The China Precision Medicine Cloud: A world-leading platform to benefit patients and health
WuXi AppTec’s Pharmaceutical Development Service and Analytical Service Passes EMA Inspection
WuXi Biologics Congratulates TESARO for Anti-TIM-3 Antibody IND Submission in the U.S..
WuXi Healthcare Ventures Appoints Renowned Life Science Entrepreneur, Gregory Verdine, Ph.D. as newest Venture Partner
WuXi AppTec Acquires Crelux